Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) Share Price

Company Profile

Business description
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.
Contact
979 King’s Road
43rd Floor, One Taikoo Place
Quarry Bay
Hong Kong
HKG
https://www.interlong.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,474

Recommended

This share is trading at the lowest price to fair value of the 14 companies on the list.

Angus Hewitt, CFA | 05 January 2026

Despite a surging share price a weakening competitive position causes a reassessment of our view.

Shane Ponraj, CFA | 05 January 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.

Margaret Giles | 04 January 2026

Index	Last price	Change	% Change
All Ordinaries	8,996.90	37.80	-0.42%
CAC 40	8,247.33	35.83	0.44%
DAX 40	24,896.94	28.25	0.11%
Dow JONES (US)	49,198.70	221.52	0.45%
FTSE 100	10,132.02	127.45	1.27%
HKSE	26,710.45	363.21	1.38%
NASDAQ	23,435.53	39.70	0.17%
Nikkei 225	52,518.08	685.28	1.32%
NZX 50 Index	13,663.58	76.35	0.56%
S&P 500	6,918.15	16.10	0.23%
S&P/ASX 200	8,682.80	45.80	-0.52%
SSE Composite Index	4,083.67	60.25	1.50%